{"id":"W2735558737","doi":"10.1111/1346-8138.13956","title":"Tofacitinib for the treatment of moderate to severe chronic plaque psoriasis in Japanese patients: Subgroup analyses from a randomized, placebo‐controlled phase 3 trial","year":2017,"lang":"en","type":"article","venue":"The Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":29,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research","funders":"Pfizer","keywords":"Tofacitinib; Medicine; Janus kinase inhibitor; Placebo; Dermatology Life Quality Index; Adverse effect; Internal medicine; Psoriasis; Psoriasis Area and Severity Index; Randomized controlled trial; Dermatology; Gastroenterology; Rheumatoid arthritis; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037247,0.001727135,0.004797311,0.0006135362,0.0005314279,0.001128794,0.0005597267,0.001095992,0.003169282],"category_scores_gemma":[0.002677187,0.0005627649,0.009190358,0.0007969471,0.0004105046,0.0005303156,0.000464953,0.001277121,0.0002314195],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006950632,"about_ca_system_score_gemma":0.001464161,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001802997,"about_ca_topic_score_gemma":0.007274067,"domain_scores_codex":[0.9986506,0.0006659879,0.0002238577,0.0001826425,0.0001088986,0.0001680777],"domain_scores_gemma":[0.998915,0.000374643,0.0002826211,0.0001301613,0.0001048996,0.0001927186],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9114928,0.00087589,0.006774817,0.004039322,0.04912046,0.0002124811,0.0001592119,0.0005320435,0.004788885,0.0001161225,0.001415071,0.02047282],"study_design_scores_gemma":[0.8221757,0.02218003,0.03737109,0.0003089925,0.1120568,0.0002588543,0.0001924214,0.0012598,0.0008995011,0.000674428,0.002528573,0.00009370343],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9263965,0.06094572,0.001776829,0.001034365,0.0008607687,0.003896726,0.002826409,0.000128996,0.002133624],"genre_scores_gemma":[0.9826055,0.008510702,0.001295796,0.0009370717,0.0004971755,0.003240353,0.001896795,0.00002820381,0.0009884575],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004797311,"threshold_uncertainty_score":0.01969832,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03964438293804168,"score_gpt":0.3271279445394759,"score_spread":0.2874835616014342,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}